NHS Logo

Biologic Therapy for Psoriasis (Record no. 102039)

MARC details
000 -LEADER
fixed length control field 03767nam a22004455i 4500
001 - CONTROL NUMBER
control field 978-3-030-92938-1
003 - CONTROL NUMBER IDENTIFIER
control field DE-He213
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20240729134813.0
007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION
fixed length control field cr nn 008mamaa
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 220217s2022 sz | s |||| 0|eng d
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
ISBN 9783030929381
-- 978-3-030-92938-1
072 #7 - SUBJECT CATEGORY CODE
Subject category code MJK
Source bicssc
072 #7 - SUBJECT CATEGORY CODE
Subject category code MED017000
Source bisacsh
072 #7 - SUBJECT CATEGORY CODE
Subject category code MJK
Source thema
245 10 - TITLE STATEMENT
Title Biologic Therapy for Psoriasis
Subtitle : Cutting Edge Treatment Principles /
250 ## - EDITION
Edition statement 1st ed. 2022.
264 #1 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Place of production, publication, distribution, manufacture Cham :
Name of producer, publisher, distributor, manufacturer Springer International Publishing :
-- Imprint: Springer,
Date of production, publication, distribution, manufacture, or copyright notice 2022.
300 ## - PHYSICAL DESCRIPTION
Physical description XVII, 146 p. 5 illus., 4 illus. in color.
Other physical details online resource.
336 ## - CONTENT TYPE
Content type term text
Content type code txt
Source rdacontent
337 ## - MEDIA TYPE
Media type term computer
Media type code c
Source rdamedia
338 ## - CARRIER TYPE
Carrier type term online resource
Carrier type code cr
Source rdacarrier
490 1# - SERIES TITLE
Series statement Updates in Clinical Dermatology,
International Standard Serial Number 2523-8892
505 0# - CONTENTS
Contents Introduction to Biologic Therapy for Psoriasis -- Laboratory Monitoring: TB, Hepatitis and HIV -- TNF-Alpha Class of Biologic Agents in Psoriatic Disease -- IL-17 class of Biologic Agents in Psoriatic Disease -- IL-23 Inhibition for the Treatment of Psoriatic Disease: Pathway Discovery and Overview -- Combination Therapy with Biologic Agents -- Biologic Agents for the Treatment of Pediatric Psoriasis -- Special Site Psoriasis -- Comparing Biologic Agents in Treatment of Psoriasis -- Long Term Registry Data for Psoriasis Biologics -- Psoriasis Biologic Agents in Special Populations -- Psoriasis Biologics and the COVID-19 Pandemic: Lessons Learned -- Adherence to Biologic Therapy for Psoriasis.
520 ## - ABSTRACT
Abstract Biologic therapy is a treatment that strives to modulate a patient's immune system to fight a given disease. In psoriasis, a skin disorder that is partly caused by a dysregulated immune system resulting in well-demarcated red areas of the skin with white scales, biologic therapy has the potential to vastly improve upon patient outcomes by minimizing the symptoms of this disease while maximizing the safety profile of the therapy. This book offers an up-to-date and comprehensive review on biologic therapy for the treatment of psoriasis. With over 10 FDA approved biologic agents for psoriasis (with more in the pipeline), confusion exists among providers regarding which agent is best for a particular patient. Chapters cover all FDA approved psoriasis biologic agents (including pipeline agents) for use in pediatric, adult, and geriatric patients. This book is unique in that it will not only cover cutting edge treatment principles based on the latest research, it will also be one of the most comprehensive reviews of psoriasis biologics in the COVID-19 era. Biologic Therapy for Psoriasis is a must-have resource for board certified dermatologists and rheumatologists, dermatology and rheumatology residents and fellows, dermatology physician assistants, nurse practitioners and medical students. The ultimate goal of this book is to improve patient care by making the busy practicing dermatology provider more adept with these particular therapies.
650 #0 - SUBJECT HEADINGS
Subject term Dermatology.
9 (RLIN) 5856
650 14 - SUBJECT HEADINGS
Subject term Dermatology.
9 (RLIN) 5856
700 1# - ADDED PERSONAL NAME
Added personal author Brownstone, Nicholas.
Relator term editor.
700 1# - ADDED PERSONAL NAME
Added personal author Bhutani, Tina.
Relator term editor.
700 1# - ADDED PERSONAL NAME
Added personal author Liao, Wilson.
Relator term editor.
710 2# - ADDED CORPORATE NAME
Added corporate author SpringerLink (Online service)
830 #0 - SERIES ADDED ENTRY--UNIFORM TITLE
Uniform title Updates in Clinical Dermatology,
International Standard Serial Number 2523-8892
856 ## - ONLINE RESOURCE
Uniform Resource Identifier <a href="#gotoholdings">#gotoholdings</a>
Link text Access resource
245 ## - TITLE STATEMENT
Medium [E-Book]
347 ## - DIGITAL FILE CHARACTERISTICS
File type text file
Encoding format PDF
Source rda
912 ## -
-- ZDB-2-SME
912 ## -
-- ZDB-2-SXM
Holdings
Withdrawn status Lost status Damaged status Not for loan Home library Current library Shelving location Date acquired Source of acquisition Total Checkouts Date last seen Uniform Resource Identifier Price effective from Koha item type
        Hillingdon Hospitals Library Services (Hillingdon Hospitals NHS Foundation) Hillingdon Hospitals Library Services (Hillingdon Hospitals NHS Foundation) Online 02/05/2024 Springer BiomedLifeSc   02/05/2024 https://go.openathens.net/redirector/nhs?url=https://doi.org/10.1007/978-3-030-92938-1 02/05/2024 Electronic book
London Health Libraries Consortium Privacy notice and Membership terms and conditions